Document:

Amended and Restated 2002 Equity Compensation Plan

 Exhibit 10.50 
 DaVita Inc. 
 2002 Equity Compensation Plan 
 (As Amended and Restated Effective January 1, 2009) 
 1. Purpose. The purpose of the DaVita Inc. 2002 Equity Compensation Plan (“Plan”) is to promote the interests of DaVita Inc. (“Company”) and its stockholders by enabling the Company
to offer an opportunity to acquire an equity interest in the Company so as to better attract, retain, and reward Employees, directors, and independent contractors and, accordingly, to strengthen the mutuality of interests between those persons and
the Company’s stockholders by providing those persons with a proprietary interest in pursuing the Company’s long-term growth and financial success. Awards under the Plan will be made in the form of the issuance of Options, Restricted
Stock, Stock Issuances, Stock Appreciation Rights, and Other Awards. 
 2. Definitions. For purposes of this Plan, the
following terms shall have the meanings set forth below. 
 (a) “Board” or “Board of Directors” means the Board of
Directors of DaVita Inc. 
 (b) “Code” means the Internal Revenue Code of 1986. Reference to any specific section of the Code shall
also be deemed to be a reference to any successor provision. 
 (c) “Committee” means the administrative committee of this Plan
that is provided for in Section 3 of this Plan. 
 (d) “Common Stock” means the common stock of DaVita Inc. or any security
issued in substitution, exchange, or in lieu thereof. 
 (e) “Company” means DaVita Inc., a Delaware corporation, or any successor
corporation. Except where the context indicates otherwise, the term “Company” shall include its Parent and Subsidiaries, if any. 
 (f) “Disabled” means permanent and total disability, as defined in Code Section 22(e)(3). 
 (g) “Effective
Date” of this Plan is April 11, 2002. 
 (h) “Employee” means a worker whose earnings the Company reports on a Form W-2.

 (i) “Exchange Act” means the Securities Exchange Act of 1934. 
  

 1 

 (j) “Fair Market Value” of Common Stock for any day shall, except as otherwise provided below,
be the last reported sale price on that day regular way, or if no such reported sale takes place on that day, the average of the last reported bid and ask prices on that day regular way, in either case on the principal national securities exchange
on which the Common Stock is traded or listed. 
  

	 	(i)	If the national securities exchange is closed on such date, the “Fair Market Value” shall be determined as of the last preceding day on which the Common Stock was traded
or for which bid and ask prices are available. 

  

	 	(ii)	In the case of an Incentive Stock Option, “Fair Market Value” shall be determined without reference to any restriction other than one that, by its terms, will never lapse.

  

	 	(iii)	In the case of the settlement of a Stock Appreciation Right, “Fair Market Value” of Common Stock shall mean the last reported sale price on the most recently closed
trading day regular way, or if no such reported sale takes place on that day, the average of the last reported bid and asked prices on that day regular way, in either case on the principal national securities exchange on which the Common Stock is
traded or listed. 

 (k) “Grants” mean awards of Options, Restricted Stock, Stock Issuances, Stock Appreciation
Rights, and Other Awards. 
 (l) “Incentive Stock Option” means an option to purchase Common Stock that is intended to be an
incentive stock option under Code Section 422. 
 (m) “Insider” means a person who is subject to Section 16 of the
Exchange Act. 
 (n) “Non-Qualified Stock Option” means any option to purchase Common Stock that is not an Incentive Stock
Option. 
 (o) “Option” means an Incentive Stock Option or a Non-Qualified Stock Option. 
 (p) “Other Awards” mean equity-based awards that are not Options, Restricted Stock, Stock Appreciation Rights, or Stock Issuances. However, in
the event that the Other Award is the functional equivalent of Restricted Stock or Stock Issuance, (i) the special share-counting rule contained in Section 5(a)(iv) and (ii) the vesting limitations contained in Section 7(e) shall
apply. 
 (q) “Parent” means any corporation (other than the Company) in an unbroken chain of corporations ending with the
Company if each of the corporations (other than the Company) owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in the chain, as determined in
accordance with the rules of Code Section 424(e). 
 (r) “Participant” means a person who has received a Grant. 
  

 2 

 (s) “Plan” means this DaVita Inc. 2002 Equity Compensation Plan. 
 (t) “Predecessor Plans” mean the DaVita Inc. 1994 Equity Compensation Plan, 1995 Equity Compensation Plan, 1997 Equity Compensation Plan, and
1999 Equity Compensation Plan. 
 (u) “Restricted Stock” means the shares of Common Stock that are issued to a Participant, where
the Participant does not immediately possess a vested right to those shares. Nevertheless, the terms of a Grant may provide for faster vesting in limited situations of retirement, death, disability, change in control, and/or grants to newly-hired
Employees. Other than the right to sell or otherwise transfer the shares and such other restrictions as may be contained in the Grant, the Participant shall be treated as the owner of the Restricted Stock (e.g., for voting purposes) from the
date of the issuance of the shares. 
 (v) “Rule 16b-3” means Rule 16b-3 promulgated by the Securities and Exchange Commission.

 (w) “Section 162(m)” means Code Section 162(m), which imposes a million dollar ($1,000,000) compensation deduction
limitation on amounts paid to certain senior executives. 
 (x) “Service” means the performance of service, whether as an Employee
or as an independent contractor (e.g., as a member of the Board ). 
  

	 	(i)	Nevertheless, except to the extent otherwise expressly provided to the contrary in the terms of the Grant, service performed by the Participant shall only be taken into account to
the extent it is performed in the same capacity as on the date of the Grant (that is, as an Employee or as an independent contractor). In making the determination as to whether or not a Grant should provide for the continuation of Service after a
change in status, the Committee shall take into account the relevant possible tax and accounting consequences. 

  

	 	(ii)	The Committee shall prescribe such rules as it may deem necessary or appropriate regarding crediting of periods of Service while a Participant is on a leave of absence.

 (y) “Severance” means, with respect to a Participant, the termination of the Participant’s Service, whether
by reason of death, disability, or any other reason. 
  

	 	(i)	For purposes of determining the exercisability of an Incentive Stock Option, a Participant who is on a leave of absence that exceeds ninety (90) days will be considered to have
incurred a Severance on the ninety-first (91st) day of the leave of absence, unless the Participant’s rights to reemployment are guaranteed by statute or contract. 

  

	 	(ii)	A Participant will not be considered to have incurred a Severance because of a transfer between the Company, Subsidiary, or Parent. 

  

 3 

	 	(iii)	If a Participant switches from Employee to independent contractor status or vice versa, that will be treated as a Severance, except as otherwise expressly provided to the contrary
in the terms of the Grant. 

  

	 	(iv)	If a Participant switches from Employee to independent contractor status, that will result in an Option losing its status as an Incentive Stock Option after ninety (90) days
has elapsed since the switch. Thereafter, the Option (if it is exercisable at all) will be treated as a Non-Qualified Stock Option. 

 (z) “Stock Appreciation Right” means the right to receive a payment equal to the difference between the Fair Market Value of the Common Stock on the date of its issuance and the date on which the right is exercised. Stock
Appreciation Rights may be settled in cash or Common Stock. 
 (aa) “Stock Issuance” means the direct issuance of fully vested
shares to an Employee or an independent contractor (including a director) for compensation previously earned. The shares may be issued immediately or on a deferred basis. 
 (bb) “Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each of the corporations (other than the last corporation in
the unbroken chain) owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in the chain, as determined in accordance with the rules of Code
Section 424(f). 
 (cc) “Substitute Grant” means an award issued to a person who had performed services for an entity that was
acquired by the Company in substitution of a grant previously awarded to that individual or entity by the acquired entity. Any such substitution shall be made in compliance with the requirements of Section 409A of the Code (to the extent
applicable thereto), including without limitation, with respect to Options and Stock Appreciation Rights, the requirements of Treasury Regulation §1.409A-1(b)(5)(v)(D). 
 (dd) “Ten Percent Stockholder” means any person who owns (after taking into account the constructive ownership rules of Code
Section 424(d)) more than ten percent (10%) of the combined voting power of all classes of stock of DaVita Inc. or of any of its Parents or Subsidiaries. 
 3. Administration. 
 (a) Except as provided below, this Plan shall be administered by the
Compensation Committee of the Board. 
 (b) If the income recognized with respect to an Option is intended to be exempt from
Section 162(m), the Committee must be composed exclusively of “Outside Directors,” as that term is defined in Section 162(m). Similarly, if a Grant to an Insider is intended to be an exempt purchase under Section 16 of the
Exchange Act, then either (i) the Committee must be composed exclusively of “Non-Employee Directors,” as that term is defined in Rule 16b-3 or (ii) the grant must be made by the Board of Directors. 
  

 4 

 (c) The Committee is authorized to interpret this Plan and to adopt rules and procedures relating to the
administration of this Plan, including those relating to sub-plans established for the purpose of qualifying for preferred tax or other treatment under foreign laws. All actions of the Committee in connection with the interpretation and
administration of this Plan shall be binding upon all parties. No member of the Committee shall incur any liability for any actions taken or inactions done in good faith. 
 (d) Subject to the limitations of Sections 9 and 14 of this Plan, the Committee is expressly authorized, to the extent permitted by Section 409A of the Code, to make such modifications to this Plan and to Grants
made under this Plan as are necessary to effectuate the intent of this Plan as a result of any changes in the tax, accounting, or securities laws treatment of Participants or of the Plan. 
 (e) The Board of Directors may, by a resolution adopted by the Board, delegate the power to issue Grants under the Plan, provided such delegation is
consistent with applicable law and the requirements of any stock exchange on which the Common Stock is traded. 
 4. Duration of
Plan. 
 (a) This Plan shall be effective as of the Effective Date. 
 (b) The Plan shall terminate on February 8, 2012, which is the tenth anniversary of the date on which the Board of Directors adopted the Plan. The
preceding sentence shall not apply if the Company’s stockholders reapprove the Plan prior to the termination date. The effect of obtaining such reapproval shall be to extend the term of the Plan for another ten (10) years from the
date on which such reapproval shall be obtained. 
 5. Number of Shares. 
 (a) The following rules shall govern the size of Grants under this Plan. 
  

	 	(i)	The base maximum number of shares of Common Stock which may be issued pursuant to this Plan is sixteen million, two hundred fifty-eight thousand, five hundred
(16,258,500) shares. In addition, three million six hundred sixteen thousand, five hundred and sixty (3,616,560) shares, representing the balance remaining in the Predecessor Plans at the Effective Date were transferred to this Plan. The
total number of shares available under the Plan will also be increased by the shares that subsequently become available under the Predecessor Plans as determined pursuant to this Plan. 

  

	 	(ii)	The maximum number of shares that may be subject to Options or Stock Appreciation Rights awarded to a single Participant in any consecutive twenty-four (24) month period is two
million two hundred fifty thousand (2,250,000). For this purpose, (A) shares subject to a terminated or expired Option or Stock Appreciation Right shall be considered to remain outstanding and (B) the repricing of an Option or Stock
Appreciation Right shall be treated as the issuance of a new Option or Stock Appreciation Right. 

  

 5 

	 	(iii)	The maximum number of shares that may be issued pursuant to Incentive Stock Options during the lifetime of the Plan is seven million five hundred thousand (7,500,000) shares.

  

	 	(iv)	To the extent that a Grant is made in the form of Restricted Stock or Stock Issuance (or an Other Award that is the functional equivalent of Restricted Stock or Stock Issuance), the
remaining share reserve in the Plan shall be reduced by an amount equal to 3.0 times the number of shares subject to that Grant. 

  

	 	(v)	To the extent that a Grant is made in the form of an Option or Stock Appreciation Right, the remaining share reserve in the Plan shall be reduced by an amount equal to 1.0 times the
number of shares subject to that Grant. 

 The preceding numbers shall be adjusted as set forth in Section 12 of this
Plan. 
 (b) If any shares of Common Stock subject to a Grant under the Plan or a Predecessor Plan are forfeited or expire, or if any Grant
under the Plan or a Predecessor Plan is settled for cash, the shares subject to the Grant shall, to the extent of such forfeiture, expiration or cash settlement, again be available for use under the Plan, subject to Section 5(d) below.
Notwithstanding anything to the contrary contained herein, the following shares shall not be added to the shares of Common Stock available for use under the Plan: (i) shares tendered by the Participant or withheld by the Company in payment of
the exercise price of an Option, (ii) shares tendered by the Participant or withheld by the Company to satisfy any tax withholding obligation with respect to a Grant, and (iii) shares subject to a Stock Appreciation Right that are not
issued in connection with the stock settlement of the Stock Appreciation Right on exercise thereof. 
 (c) Substitute Grants shall not reduce
the shares available for use under the Plan or the maximum number of shares authorized for grant to a Participant under Section 5(a)(ii). Additionally, in the event that a corporation acquired by the Company or any Subsidiary or with which the
Company or any Subsidiary combines has shares available under a pre-existing plan approved by stockholders of such corporation and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms
of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common
stock of the corporation party to such acquisition or combination) shall be added to the shares available for use under the Plan; provided that Grants using such available shares shall not be made after the date Grants could no longer have been made
under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees or members of the Board of Directors prior to such acquisition or combination. 
  

 6 

 (d) Any shares that again become available for Grant pursuant to Section 5(b) shall be added back as
(i) 1 share if such shares were subject to Options or Stock Appreciation Rights granted under the Plan or a Predecessor Plan, and (ii) as 3 shares if such shares were subject to Grants other than Options or Stock Appreciation Rights.

 6. Eligibility. 
 (a) Persons eligible to receive Grants under this Plan shall consist of (i) Employees, (ii) members of the Board of Directors, and (iii) other persons providing Services to the Company or a Subsidiary, other than
persons only providing Services in connection with a capital raising transaction. However, Incentive Stock Options may only be awarded to Employees. 
 (b) In the event that the Company acquires another entity, the Committee may authorize the issuance of Substitute Grants upon such terms and conditions as the Committee shall determine, which may be different from the
terms contained in this Plan, taking into account the limitations of Code Section 424(a) in the case of a Substitute Grant that is intended to be an Incentive Stock Option. Any such Substitute Grant shall be made in compliance with the
requirements of Section 409A of the Code (to the extent applicable thereto), including without limitation, with respect to Options and Stock Appreciation Rights, the requirements of Treasury Regulation §1.409A-1(b)(5)(v)(D). 
 (c) In the event that the Committee makes a Grant to a person who is not currently an Employee of or an independent contractor providing Services to the
Company or a Subsidiary, such Grant shall not become effective until such individual commences performing Services to the Company or a Subsidiary and it must satisfy the pricing limitations set forth in Section 7 of this Plan at that time.

 (d) After taking into consideration the tax, securities, and accounting consequences of doing so, the Committee may issue Non-Qualified
Stock Options, Restricted Stock, Stock Issuances, Stock Appreciation Rights, and Other Awards to individuals who are performing Services (whether as Employees or as independent contractors) to entities that are related to or affiliated with the
Company but that do not qualify as Parents or Subsidiaries; provided, however, that Non-Qualified Stock Options and Stock Appreciation Rights may be granted to an individual only if Common Stock qualifies, with respect to such individual, as
“service recipient stock” within the meaning set forth in Section 409A of the Code. The Committee shall prescribe such rules as it deems appropriate regarding the crediting of Service in these circumstances. 
 7. Form of Grants. Gants shall be awarded under this Plan in such amounts, at such times, to such persons, on such terms and in such form
as the Committee may approve, which shall not be inconsistent with the provisions of this Plan, but which need not be identical from Grant to Grant. 
 (a) The exercise price per share of Common Stock purchasable under an Option shall be set forth in the Option, and shall not be less than the Fair Market Value of the Common Stock on the date of Grant. However, the
exercise price of an Incentive Stock Option issued to a Ten Percent Stockholder shall be no less than one hundred ten percent (110%) of the Fair Market 

  

 7 

 
Value of the Common Stock on the date of the Grant. Similarly, the base price of a Stock Appreciation Right shall not be less than the Fair Market Value of
the Common Stock on the date of the Grant. However, the preceding three sentences shall not apply in the case of Substitute Grants issued under this Plan. Similar pricing rules shall apply in the case of Other Awards. Any Substitute Grant
shall be made in compliance with the requirements of Section 409A of the Code (to the extent applicable thereto), including without limitation, with respect to Options and Stock Appreciation Rights, the requirements of Treasury Regulation
§1.409A-1(b)(5)(v)(D). 
 (b) A Grant shall be exercisable at such time or times and be subject to such terms and conditions as may be
set forth in its provisions. However, no Grant shall be exercisable prior to the Effective Date. 
 (c) Except in the case of Substitute
Grants, the aggregate Fair Market Value (determined as of the date of Grant) of the number of shares of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year shall not
exceed one hundred thousand dollars ($100,000). To the extent that a Participant’s Options exceed that limit, they will be treated as Non-Qualified Stock Options, with the first Options that were awarded to the Participant to be treated as
Incentive Stock Options. 
 (d) Except as provided in Section 10 or in the case of Substitute Grants, the term of a Grant shall not
exceed five (5) years from the date of its issuance. 
 (e) Except as may be determined by the Committee in the event of a change of
control of the Company, or the Participant’s death, disability or retirement, notwithstanding any other provision of this Plan to the contrary, a Grant to an Employee of a Stock Issuance, Restricted Stock or an Other Award that is the
functional equivalent of a Stock Issuance or Restricted Stock shall not become fully vested earlier than three years from the grant date (two years in the case of Employees who are not executives of the Company (holding the title of vice president
or an equivalent title), or, in the case of vesting based upon the attainment of performance-based objectives, over a period of not less than one year, which shall include a Stock Issuance granted in lieu of cash awards that have been earned based
on a performance period of at least one year); provided, however, that notwithstanding the foregoing, Grants of a Stock Issuance, Restricted Stock or Other Awards that are the functional equivalent of a Stock Issuance or Restricted Stock
(i) that do not exceed in the aggregate 5% of the shares of Stock available pursuant to Section 5(a)(i) shall not be subject to such minimum vesting provisions and (ii) the Company may Grant a Stock Issuance, Restricted Stock or Other
Award that is the functional equivalent of a Stock Issuance or Restricted Stock to Employees newly hired by the Company or any of its Subsidiaries without respect to such minimum vesting provisions. 
 8. Exercise of Grants. 
 (a)
Grants that are settled in stock shall only be exercisable for whole numbers of shares. 
  

 8 

 (b) Options are exercised by payment of the full amount of the purchase price to the Company as follows:

  

	 	(i)	The payment shall be in cash or such other form or forms of consideration as the Committee shall deem acceptable, such as the surrender (either actually or constructively by means
of attestation) of outstanding shares of Common Stock owned by the Participant for the minimum period of time necessary to avoid adverse accounting treatment (if applicable). 

  

	 	(ii)	After giving due consideration to the consequences under Rule 16b-3 and under the Code, the Committee may also authorize the exercise of Options by the delivery to the Company (or
its designated agent) of an executed written notice of exercise form together with irrevocable instructions to a broker-dealer to sell or margin a sufficient portion of the shares of Common Stock and to deliver the sale or margin loan proceeds
directly to the Company to pay all or a portion of the exercise price of the Option and/or any tax withholding obligations. 

 For purposes of
determining the amount of income that is recognized by a Participant pursuant to a “same-day sale” transaction described in Subparagraph (ii) above, the Fair Market Value of the Common Stock shall be the price at which the Common
Stock was sold. 
 (c) Stock Appreciation Rights may be exercised by providing notice to the Company on such terms and conditions as are set
forth in the Grant. 
 (d) Except as otherwise provided in the terms of the Grant, the Participant may exercise the Grant following his or
her Severance only to the extent that the Grant could have been exercised on the date of the Severance, so that no events that occur following Severance will increase the vested portion of the Grant. 
 (e) The Committee may, to the extent permitted by Section 409A of the Code, provide for the acceleration of the vesting of Grants upon a change of
control or similar circumstances, under such conditions as may be set forth in the terms of the Grants. 
 9. Modification of
Grants. 
 (a) After due consideration to the possible tax, securities, and accounting consequences, the Committee may, to the extent
permitted by Section 409A of the Code, modify an existing Grant, including by: 
  

	 	(i)	Accelerating the right to exercise it; or 

  

	 	(ii)	Extending or renewing it. 

 (b) In no event without first
obtaining stockholder approval will (i) the exercise or base price of any outstanding Option or Stock Appreciation Right be reduced or repriced, including any repricing effected by issuing replacement Options or Stock Appreciation Rights for
outstanding Options or Stock Appreciation Rights that have an exercise or base price greater 

  

 9 

 
than the Fair Market Value of the Common Stock, (ii) an Option or Stock Appreciation Right be canceled in exchange for cash or another Grant (other than
in connection with Substitute Grants), or (iii) any other action be taken with respect to an Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal national securities exchange
on which the Common Stock is traded or listed. 
 (c) In the event that the Board amends the terms of an Option so that it no longer
qualifies as an Incentive Stock Option, the limitations imposed upon the Option under the Code and the Plan solely by virtue of its (formerly) qualifying as an Incentive Stock Option shall no longer apply, to the extent specified in the amendment.

 (d) Whether a modification of an existing Incentive Stock Option will be treated as the issuance of a new Incentive Stock Option will be
determined in accordance with the rules of Code Section 424(h). 
 (e) Whether a modification of an existing Grant previously awarded to
an Insider will be treated as a new Grant for purposes of Section 16 of the Exchange Act will be determined in accordance with Rule 16b-3. 
 10. Termination of Grants. 
 (a) Except to the extent provided otherwise in the terms of the Grant, each Grant shall
terminate on the earliest of the following dates: 
  

	 	(i)	The date that is one (1) year from the date of the Severance of the Participant, if the Severance occurred because of the Participant’s death or Disability.

  

	 	(ii)	In the case of any Severance other than one described in Subparagraph (i) above, the date that is three (3) months from the date of the Participant’s
Severance. 

 (b) Except in the case of a Severance caused by death or Disability, in no event shall an Option or Stock
Appreciation Right be exercisable more than five (5) years after the date on which it was issued. 
 (c) The nonvested portion of the
Option or Stock Appreciation Right shall terminate immediately upon Severance, and the vested portion at the time the balance of the Option or Stock Appreciation Right terminates, as determined pursuant to the above rules. 
 (d) The nonvested portion of a Grant of Restricted Stock shall terminate immediately upon Severance. 
 11. Non-Transferability of Grants. During the lifetime of the Participant, Grants are exercisable only by the Participant, and Grants are
not assignable or transferable except by will or the laws of descent and distribution. 
  

 10 

 12. Adjustments. 
 (a) In the event of any change in the capitalization of the Company affecting its Common Stock (e.g., a stock split, reverse stock split, stock
dividend, recapitalization, combination, reclassification, or other similar transaction), the Committee shall make such adjustments as it may deem appropriate with respect to: 
  

	 	(i)	The number, kind, and exercise price of shares covered by each outstanding Grant; and 

  

	 	(ii)	The maximum number and/or kind of shares that may be awarded under this Plan, including the limitations contained in Section 5(a) of this Plan. 

 (b) The Committee shall also make such adjustments as it may deem appropriate in the event of a spin-off or other distribution of Company assets to
stockholders (other than normal cash dividends). 
 (c) Any adjustment of Grants shall be made in compliance with the requirements of
Section 409A of the Code (to the extent applicable thereto), including without limitation, with respect to Options and Stock Appreciation Rights, the requirements of Treasury Regulation §1.409A-1(b)(5)(v)(D). 
 13. Notice of Disqualifying Disposition. A Participant must notify the Company within fifteen (15) days if the Participant disposes of
stock acquired pursuant to the exercise of an Incentive Stock Option issued under the Plan or a Predecessor Plan prior to the expiration of the holding periods required to qualify for long-term capital gains treatment on the disposition. 

14. Amendments and Termination. Subject to the limitations of applicable law and any stock exchange on which the Common Stock is listed
or traded, and the requirements of Section 9(b) and this Section, the Board may at any time amend or terminate this Plan by means of written action. Furthermore, no Participant may rely upon any statement (oral or written) that is inconsistent
with the terms of the Plan or the Grant. To insure that Options can qualify as Incentive Stock Options, within twelve (12) months after the adoption of the amendment by the Board of Directors, the stockholders must approve any amendment that
changes: 
 (a) The class of Employees who are eligible to receive Incentive Stock Options; and/or 
 (b) The maximum number of shares of Common Stock that may be issued as Incentive Stock Options under the Plan, except as adjusted pursuant to
Section 12 of this Plan. 
 Notwithstanding the foregoing, the Board of Directors may not, without the approval of the Company’s stockholders,
(i) take any other action with respect to an Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal securities exchange on which the Common Stock is traded or listed,
(ii) reduce the exercise price of an Option or the grant price of a Stock Appreciation Right or (iii) exchange an Option or Stock Appreciation Right for cash or another Grant. 
  

 11 

 15. Tax Withholding. 
 (a) The Company shall have the right to take such actions as may be necessary to satisfy its tax withholding obligations relating to the operation of this
Plan. 
 (b) To the extent authorized by the Committee, Participants may (i) surrender previously acquired shares of Common Stock or
(ii) have shares withheld in satisfaction of the tax withholding obligations. To the extent necessary to avoid adverse accounting treatment, the number of shares that may be withheld for this purpose shall not exceed the minimum number
needed to satisfy the applicable income and employment tax withholding rules. Similarly, the shares surrendered must have been owned by the Participant for the minimum period of time necessary to avoid adverse accounting treatment (if applicable).

 (c) If Common Stock is used to satisfy the Company’s tax withholding obligations, the stock shall be valued at its Fair Market Value
when the tax withholding is required to be made. 
 16. No Additional Rights. 
 (a) Neither the adoption of this Plan nor the awarding of any Grant shall: 
  

	 	(i)	Affect or restrict in any way the power of the Company to undertake any corporate action; or 

  

	 	(ii)	Confer upon any Participant the right to continue performing Service for the Company, nor shall it interfere in any way with the right of the Company to terminate the Service of any
Participant at any time, with or without cause, subject to the terms of any applicable employment or consulting agreement between the Participant and the Company. 

 (b) No Participant shall have any rights as a stockholder with respect to any shares awarded to the Participant under this Plan until the date a
certificate for such shares has been issued to the Participant. 
 17. Securities Law Restrictions. 
 (a) No shares of Common Stock shall be issued under this Plan unless the Committee shall be satisfied that the issuance will be in compliance with
applicable federal and state securities laws and the requirements of any stock exchange or other securities market on which the Company’s securities may then be traded. Similarly, a Participant will not be permitted to exercise a Grant if such
exercise would violate the Company’s internal policies. 
 (b) The Committee may require certain investment (or other) representations
and undertakings by the person exercising a Grant if necessary to comply with applicable law. 
 (c) Certificates for shares of Common Stock
delivered under this Plan may be subject to such restrictions as the Committee may deem advisable. The Committee may cause a legend to be placed on the certificates to refer to those restrictions. 
  

 12 

 (d) The inability of the Company to obtain registration, qualification, or other necessary authorization,
or the unavailability of an exemption from any registration or qualification obligation deemed by the Company’s counsel to be necessary for the lawful issuance and sale of any shares of its Common Stock under this Plan shall: 
  

	 	(i)	Suspend the Company’s obligation to permit the exercise of any Grant or to issue any shares under this Plan; and 

  

	 	(ii)	Relieve the Company of any liability in respect of the nonissuance or sale of the shares as to which the requisite authority or exemption shall not have been obtained.

 18. Indemnification. 
 (a) To the maximum extent permitted by law, the Company shall indemnify each member of the Committee and of the Board, as well as any other Employee of the Company with duties under the Plan, against expenses and
liabilities (including any amount paid in settlement) reasonably incurred by the individual in connection with any claims against the individual by reason of the performance of the individual’s duties under this Plan, unless the losses are due
to the individual’s gross negligence or lack of good faith. 
 (b) The Company will have the right to select counsel and to control the
prosecution or defense of the suit. 
 (c) In the event that more than one person who is entitled to indemnification is subject to the same
claim, all such persons shall be represented by a single counsel, unless such counsel advises the Company in writing that he or she cannot represent all such persons under the applicable rules of professional responsibility. 
 (d) The Company will not be required to indemnify any person for any amount incurred through any settlement unless the Company consents in writing to the
settlement. 
 19. Application of Code Section 409A. To the extent applicable, this Plan and all Grants made hereunder are
intended to be administered and interpreted in a manner that is consistent with the requirements of Section 409A of the Code. Notwithstanding the foregoing, no particular tax result with respect to any income recognized by a Participant in
connection with a Grant is guaranteed and each Participant shall be responsible for any taxes imposed on the Participant in connection with Grants made under the Plan. 
 20. Governing Law. This Plan and all actions taken pursuant to it shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflicts of laws
provisions. 
  

 13 

 Plan History 
  

			
	February 8, 2002	  	Board of Directors of DaVita adopted the Plan, subject to stockholder approval.
		
	April 11, 2002	  	DaVita stockholders approved the adoption of the Plan.
		
	February 26, 2003	  	Board of Directors of DaVita adopted amendments to the Plan (a) authorizing grants of stock appreciation rights, restricted stock, (direct) stock issuances, and other equity-based awards, (b)
decreasing the maximum number of shares that can be issued under the Plan from 8,500,000 to 6,839,000, and (c) specifying the exact number of shares that were transferred to the Plan from the Predecessor Plans on the Effective Date (that represented
the share reserves remaining under those plans).
		
	May 21, 2003	  	DaVita stockholders approved the Plan amendments adopted by the Board of Directors of DaVita on February 26, 2003.
		
	May 21, 2004	  	Board of Directors of DaVita adjusted the number of shares available under the Plan pursuant to Section 12 of the Plan to reflect the 2004 three-for-two stock split.
		
	March 30, 2005	  	Board of Directors of DaVita adopted amendments to the Plan (a) establishing a ten year term, (b) adjusting the limit on the number of shares that can be subject to grants awarded to any
single participant in any consecutive twenty-four month period to reflect the 2004 three-for-two stock split; and (c) adjusting the maximum number of shares that may be issued pursuant to incentive stock options (within the meaning of Section 422 of
the Internal Revenue Code) to reflect the 2004 three-for-two stock split.
		
	July 25, 2006	  	Board of Directors of DaVita adopted an amendment to the Plan to include the treatment of Stock Appreciation Rights in the definition of Fair Market Value.
		
	March 2, 2007	  	Board of Directors of DaVita adopted amendments to the Plan (a) increasing the base number of shares that can be issued under the Plan from 10,258,500 to 16,258,500, (b) removing the liberal
share recycling provisions from the Plan and (c) changing the full value share counting ratio to 3.0 from 2.75.
		
	December 10, 2008	  	Compensation Committee of DaVita adopted amendments to the Plan to reflect the final regulations issued under Section 409A of the Code.

  

 14Form of Restricted Stock Unit Agreement

 Exhibit 10.63 
 Restricted Stock Units Award under 
 the DaVita Inc. 2002 Equity Compensation Plan 

- Employee 
 [Address] 
 In recognition of your continuing contributions toward making DaVita the Greatest Dialysis Company the World has ever seen, and as a reward for your hard work and
commitment to living our Mission and our Values, you have been granted this award (the “Award”) of restricted stock units (“Restricted Stock Units” or “Units”) under DaVita’s 2002 Equity Compensation Plan (the
“Plan”). This award represents your right to receive shares of common stock of DaVita Inc. (the “Company”), subject to your fulfillment of the vesting conditions set forth in this agreement (the “Agreement”).

 The terms of your Award are as set forth in this Agreement and in the Plan. The Plan is incorporated into this Agreement by reference, which means that
this Agreement is limited by and subject to the terms of the Plan. In the event of a conflict between the terms of this Agreement and the terms of the Plan, the terms of the Plan will control. Capitalized terms that are used here but that are not
defined in this Agreement have the meanings given to them in the Plan. The most important terms of the Award are summarized as follows: 
  

			
	1. Award Date:	 	
		
	2. Number of Units:	 	
		
	3. Vesting Schedule:	 	

 The terms set forth above, together with the terms and conditions attached, constitute
one agreement. 
 Note: Please mark and initial any correction to the Name, SSN and/or Address shown on this page before returning a
signed copy of this agreement to the Stock Plan Administrator. 

 4. Conversion of Restricted Stock Units and Stock Issuance. Upon each vesting date of the Award (each, a
“Vesting Date”), one share of Common Stock will become issuable to you for each Restricted Stock Unit that vests on such Vesting Date (the “Shares”). After the Vesting Date, the Company will issue the Shares to you, after
reducing the Shares by a number of shares (if any) that are sold to satisfy your tax withholding obligations. No fractional shares will be issued under this Agreement, even though such fractions may result if a portion of a share must be sold to pay
your withholding taxes. 
 5. Termination of Employment. You must be an employee of the Company on a Vesting Date in order to receive the Shares then
vesting. Thus, Restricted Stock Units will not continue to vest if your employment terminates for any reason, including in the event you die, become disabled, retire, or change status to that of an independent contractor. In those circumstances, you
will forfeit your right to any Restricted Stock Units that would otherwise vest after the date on which your employment is terminated. 
 6. Right to
Shares. You will not have any right to the Shares subject to your Award until they are actually issued to you. 
 7. Taxes. 
 (a) Generally. You are ultimately liable and responsible for all taxes owed in connection with the Award, regardless of any action the Company or
any of its Subsidiaries takes with respect to any tax withholding obligations that arise in connection with the Award. Neither the Company nor any of its Subsidiaries makes any representation or undertaking regarding the treatment of any tax
withholding in connection with the grant or vesting of the Award or the subsequent sale of Shares issuable pursuant to the Award. The Company and its Subsidiaries do not commit and are under no obligation to structure the Award to reduce or
eliminate your tax liability. As a condition and term of this Award, no election under 83(b) of the United States Internal Revenue Code may be made by you or any other person with respect to all or any portion of the Award. 
 (b) Payment of Withholding Taxes. Prior to any event in connection with the Award (e.g., vesting) that the Company determines may result in any
domestic or foreign tax withholding obligation, whether national, federal, state or local, including any social tax obligation (the “Tax Withholding Obligation”), you must arrange for the satisfaction of the minimum amount of such Tax
Withholding Obligation in a manner acceptable to the Company. You may choose to satisfy your tax obligation in either of the following manners: 
 (i) By Sale of Shares. Unless you choose to satisfy the Tax Withholding Obligation by some other means in accordance with clause (ii) below, your acceptance of this Award constitutes your instruction and
authorization to the Company and any brokerage firm determined acceptable to the Company for such purpose to withhold or sell on your behalf a whole number of Shares from those Shares issuable to you as the Company determines to be appropriate to
generate cash proceeds sufficient to satisfy the Tax Withholding Obligation. Such Shares will be sold on the day the tax Withholding Obligation arises (e.g., a Vesting Date) or as soon thereafter as practicable. You will be responsible for all
broker’s fees and other costs of sale, and you agree to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale. To the extent the proceeds of such sale exceed your Tax Withholding
Obligation, the Company agrees to pay such excess in cash to you through payroll or otherwise as soon as practicable. You acknowledge that the Company or its designee is under no obligation to arrange for such sale at any particular price, and that
the proceeds of any such sale may not be sufficient to satisfy your Tax Withholding Obligation. Accordingly, you agree to pay to the Company or any of its Subsidiaries as soon as practicable, including through additional payroll withholding, any
amount of Tax Withholding Obligation that is not satisfied by the sale of Shares described above. 
 (ii) By Check, Wire Transfer
or Other Means. At any time not less than ten (10) business days before any Tax Withholding Obligation arises (e.g., a Vesting Date), you may notify the Company of your intent to make a separate cash payment to satisfy your Tax
Withholding Obligation. If you elect to satisfy your Tax Withholding Obligation in this manner, you will be asked to remit to the Company an amount that the Company determines is sufficient to satisfy the Tax Withholding Obligation within ten (10)
business days after the Vesting Date by (a) delivery of a certified check payable to the Company, attn: Dan Chandler, Stock Plan Administrator, P.O Box 2076, Tacoma, Washington 98401-2076, or such other address as the Company may from time to time
direct, (b) wire transfer to such account as the Company may direct, or (c) such other means as the Company may establish or permit. If you do not remit this amount to the Company within twenty (20) business days after the Vesting Date, the Company
reserves the right to satisfy your Tax Withholding Obligation in the manner set out under paragraph (i) above in its sole discretion. 

 (c) Right to Retain Shares. The Company will not be able to issue any Shares to you until you
satisfy the Tax Withholding Obligation. 
 8. Assignment. Your interest in this Award may not be assigned or alienated, whether voluntarily or
involuntarily. 
 9. Amendments. This Award may be amended only by means of a written document signed by both you and the Company.
Notwithstanding the foregoing, if there is a meaningful reduction, determined in the Company’s sole discretion, in your duties and responsibilities and the level of your regular cash compensation for an extended or indefinite period of time,
the Company reserves the right to unilaterally revoke some or all of the unvested portion of the Award.  
 10. Change of Control of the Company.
Under certain circumstances, if the Company is sold, your entire Award will vest immediately. The specific rules regarding the circumstances in which full vesting would occur are contained in an exhibit to this Agreement. 
 11. Non-Competition/Non-Solicitation/Non-Disclosure 
 (a) You acknowledge and recognize the highly competitive nature of the business of the Company and accordingly agree that while you are an employee of the Company and for the one-year period following termination of such relationship, you
will not (i) engage in or become an employee, director, principal or shareholder of, consultant to or equity participant in, any person, firm, partnership in, any person, firm, partnership, joint venture, association, corporation or other
business organization, entity, or enterprise other than the Company that engages in activities that are in competition with the Company in the United States; (ii) directly or indirectly, own, manage, control, operate, invest in, acquire an
interest in, or otherwise engage in, act for, or act on behalf of any person firm, partnership, joint venture, association, corporation or other business organization, entity, or enterprise other than the Company that engages in activities that are
in competition with the Company; (iii) be an officer, director, consultant, partner, employee, creditor, agent, trustee, independent contractor, or advisor on a paid or unpaid basis of any person, firm, partnership, joint venture, association,
corporation or other business organization, entity, or enterprise that has been a supplier to or client of the Company; (iv) be an officer, director, consultant, partner, owner, employee, creditor, agent, trustee, independent contractor, or
advisor on a paid or unpaid basis of any physician group or physician partners who provide nephrology-related services; (v) (x) directly or indirectly induce any employee of the Company, its affiliates or its subsidiaries or any physician
with privileges at a dialysis facility owned by the Company, its affiliates or its subsidiaries to (A) engage in any activity that you have agreed to refrain from pursuant to (i)-(iv) above or (B) terminate his or her relationship
with the Company or any of its affiliates or subsidiaries or (y) directly or indirectly employ, or offer employment to or other similar arrangement with, any person who is or was during the period of your employment or consulting or advisory
relationship with the Company, or was beforehand, employed or engaged by the Company, its affiliates or subsidiaries, including but not limited to a medical director of a dialysis facility owned or operated by the Company, its subsidiaries or
affiliates, or a physician with admitting privileges at a dialysis facility owned, operated or managed by Company, or one of its affiliates or subsidiaries, or (vi) take any action that results, or might reasonably result in any of the
foregoing. 
 (b) In addition, you agree not to disclose or use for your own benefit or purposes or for the benefit or purposes of any
person, firm, partnership, joint venture, association, corporation or other business organization, entity or enterprise other than the Company and any of its subsidiaries or affiliates, any trade secrets, information, data, or other confidential
information relating to customers, development, programs, costs, marketing, trading, investment, sales activities, promotion, credit and financial data, financing methods, plans, or the business and affairs of the Company (“Information”);
provided, however, the foregoing shall not apply to (i) Information which is not unique to the Company, or (ii) Information which is generally known to the industry or the public other than as a result of your breach of this covenant, or (iii)
disclosure that is required by any applicable law, rule or regulation. If you receive such a request to produce Information in your possession, you shall provide Company reasonable advance notice, in writing, prior to producing said Information, so
as to give Company reasonable time to object to your producing said Information. You also agree that you will not become employed by or enter into service with any person, firm, partnership, joint venture, association, corporation or other business
organization, entity or enterprise other than the Company and any of its subsidiaries or affiliates in which you will be obligated to disclose or use any Information, or where such disclosure would be inevitable because of the nature of the
position. 

 (c) If, at any time within (a) the Term of this Agreement, or (b) one (1) year after
termination of employment for any reason, whichever is the latest, you (i) breach the non-competition provision of Section 11(a), (ii) breach the non-solicitation provision of Section 11(a), (iii) breach the non-disclosure
provision of Section 11(b), (iv) are convicted of a felony, (v) have been adjudicated by a court of competent jurisdiction of having committed an act of fraud or dishonesty resulting or intending to result directly or indirectly in
personal enrichment at the expense of the Company, or (vi) are excluded from participating in any federal health care program, then (1) this Agreement shall terminate effective on the date on which you enter into such activity, and
(2) the Company may seek temporary, preliminary, and permanent injunctive relief to prevent any actual or threatened breach or continuation of any breach of this Agreement without the necessity of proving actual damages or posting a bond or
other security (which you hereby agree to) and/or an order requiring you to repay the Company any consideration received by you as a result of this Award under this Agreement. 
 12. Execution of Award Agreement. This agreement may be considered null and void at the discretion of the Company if a signed copy is not returned to the Stock Plan Administrator for the Company by NO LATER
THAN July 31, 2005. 
 13. Section 409A of the Code. This Agreement is intended to meet the requirements of Section 409A of the
Code, and shall be interpreted and construed consistent with that intent. Notwithstanding any other provision of this Agreement, to the extent that the right to any issuance of Common Stock or payment to you hereunder provides for the “deferral
of compensation” within the meaning of Section 409A(d)(1) of the Code, the issuance or payment shall be made in accordance with the following: 
 If you are a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code on the date of your “separation from service” within the meaning of Section 409A(a)(2)(A)(i) of the Code (the
“Separation Date”), then no such issuance of Common Stock or payment shall be made during the period beginning on the Separation Date and ending on the date that is six months following the Separation Date or, if earlier, on the date of
your death, if the earlier making of such issuance of Common Stock or payment would result in tax penalties being imposed on you under Section 409A of the Code. The amount of any issuance of Common Stock or payment that would otherwise be made
during this period shall instead be made on the first business day following the date that is six months following the Separation Date or, if earlier, the date of your death. 
 In Witness Whereof, the Company and the Award recipient have executed this Agreement as of the date first written above. 
  

					
	Recipient	 		 	Company
			
	  
	 		 	  

	Printed Name	 		 	Printed Name
			
	  
	 		 	  

	Signature	 		 	Signature
			
	  
	 		 	  

	Title	 		 	Title
			
	  
	 		 	  

	Division/Department	 		 	Division/Department

 EXHIBIT 
 Events Causing Full Vesting Awards 
 In the event that either (i) in connection with a “Change of
Control” (defined below), the “Acquiror” (defined below) fails to assume, convert or replace this Award, or (ii) your employment is terminated within the twenty-four (24) month period following a Change of Control by the
Company (or the Acquiror) other than for “Cause” (defined below) or, if applicable, by you in accordance with the termination for “Good Reason” provisions of your employment agreement, if any, then, in any such case, this Award
shall automatically vest and become immediately exerciseable in its entirety, such vesting to be effective as of immediately prior to the effective date of the Change of Control in the case of (i), and as of the date of termination of your
employment in the case of (ii). 
 Change of Control will mean: 
 (i) any transaction or series of transactions in which any person or group (within the meaning of Rule 13d-5 under the Exchange Act and Sections 13(d) and 14(d) under the Exchange Act) becomes the direct or indirect “beneficial
owner” (as defined in Rule 13d-3 under the Exchange Act), by way of a stock issuance, tender offer, merger, consolidation, other business combination or otherwise, of greater than 50% of the total voting power (on a fully diluted basis as if
all convertible securities had been converted and all warrants and options had been exercised) entitled to vote in the election of directors of the Company (including any transaction in which the Company becomes a wholly-owned or majority-owned
subsidiary of another corporation), or 
 (ii) any merger or consolidation or reorganization in which the Company does not survive, or 
 (iii) any merger or consolidation in which the Company survives, but the shares of the Company’s Common Stock outstanding immediately prior to such merger or
consolidation represent 50% or less of the voting power of the Company after such merger or consolidation, or 
 (iv) any transaction in which more than 50%
of the Company’s assets are sold. 
 However, no transaction contemplated by clauses (i) through (iv) above shall constitute a Change of
Control if both (x) the person acting as the Chief Executive Officer of the Company for the six months prior to such transaction becomes the Chief Executive Officer or the Executive Chairman of the Board of Directors of the entity that has
acquired control of the Company as a result of such transaction (the “Acquiror”) immediately after such transaction and remains the Chief Executive Officer or Executive Chairman of the Board of Directors for not less than one year
following the transaction and (y) a majority of the Acquiror’s board of directors immediately after such transaction consist of persons who were directors of the Company immediately prior to such transaction. For purposes of this
Agreement, “Cause” means: (1) a material breach by you of your duties and responsibilities which do not differ in any material respect from your duties and responsibilities during the ninety (90) day period immediately prior to a
Change in Control (other than as a result of incapacity due to physical or mental illness) which is demonstrably willful and deliberate on your part, which is committed in bad faith or without reasonable belief that such breach is in the best
interests of the Company and which is not remedied in a reasonable period of time after receipt of written notice from the Company specifying such breach; (2) willful misconduct or gross negligence which results in material harm to the Company;
or (3) your conviction of, or a plea of nolo contendere by the you, to a felony or other crime involving fraud or dishonesty; or (4) willful violation of Company policies which results in material harm to the Company.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00154-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00154-of-00352.parquet"}]]